Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sitagliptin Phosphate Tablets

Approval Number

国药准字H20244049

Company浙江永太药业有限公司

Registration Date

June 18, 2024

Drug Information

Generic Name

磷酸西格列汀片

Dosage Form

片剂

Strength

25mg（按C₁₆H₁₅F₆N₅O计）

Drug Type

化学药品

Registration Date

June 18, 2024

Company Information

Applicant Company

Company Name浙江永太药业有限公司

Company Address

浙江省化学原料药基地临海园区

Manufacturing Company

Company Name浙江永太药业有限公司

Company Address

浙江省化学原料药基地临海园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

磷酸西格列汀片 - NMPA 批准文号 | MedPath